Annual Cash & Cash Equivalents
$15.74 M
-$24.83 M-61.20%
December 31, 2022
Summary
- As of February 9, 2025, BTTX annual cash & cash equivalents is $15.74 million, with the most recent change of -$24.83 million (-61.20%) on December 31, 2022.
- During the last 3 years, BTTX annual cash & cash equivalents has risen by +$14.98 million (+1979.26%).
- BTTX annual cash & cash equivalents is now -61.20% below its all-time high of $40.57 million, reached on December 31, 2021.
Performance
BTTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.60 M
+$402.00 K+6.49%
September 30, 2023
Summary
- As of February 9, 2025, BTTX quarterly cash and cash equivalents is $6.60 million, with the most recent change of +$402.00 thousand (+6.49%) on September 30, 2023.
- Over the past year, BTTX quarterly cash and cash equivalents has dropped by -$15.71 million (-70.42%).
- BTTX quarterly cash and cash equivalents is now -83.74% below its all-time high of $40.57 million, reached on December 31, 2021.
Performance
BTTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BTTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.2% | -70.4% |
| 3 y3 years | +1979.3% | - |
| 5 y5 years | +1979.3% | - |
BTTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.2% | at low | -83.7% | +8.7% |
| 5 y | 5-year | -61.2% | >+9999.0% | -83.7% | +2555.1% |
| alltime | all time | -61.2% | >+9999.0% | -83.7% | +2555.1% |
Better Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $6.60 M(+6.5%) |
| Jun 2023 | - | $6.20 M(+2.1%) |
| Mar 2023 | - | $6.07 M(-61.4%) |
| Dec 2022 | $15.74 M | $15.74 M(-29.4%) |
| Sep 2022 | - | $22.30 M(-24.9%) |
| Jun 2022 | - | $29.68 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $31.67 M(-21.9%) |
| Dec 2021 | $40.57 M(>+9900.0%) | $40.57 M(>+9900.0%) |
| Sep 2021 | - | $248.50 K(-88.3%) |
| Jun 2021 | - | $2.12 M |
| Dec 2020 | $123.00 K(-83.8%) | - |
| Dec 2019 | $757.00 K | - |
FAQ
- What is Better Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Better Therapeutics?
- What is Better Therapeutics annual cash & cash equivalents year-on-year change?
- What is Better Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Better Therapeutics?
- What is Better Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Better Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BTTX is $15.74 M
What is the all time high annual cash & cash equivalents for Better Therapeutics?
Better Therapeutics all-time high annual cash & cash equivalents is $40.57 M
What is Better Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BTTX annual cash & cash equivalents has changed by -$24.83 M (-61.20%)
What is Better Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BTTX is $6.60 M
What is the all time high quarterly cash and cash equivalents for Better Therapeutics?
Better Therapeutics all-time high quarterly cash and cash equivalents is $40.57 M
What is Better Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BTTX quarterly cash and cash equivalents has changed by -$15.71 M (-70.42%)